Taro Pharmaceutical Industries Ltd. (TARO) Stock Overview
Explore Taro Pharmaceutical Industries Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Taro Pharmaceutical Industries Ltd. (TARO)
Key Financials
Key Financials
Market Cap
1.6B
P/E Ratio
29.99
EPS (TTM)
$1.43
ROE
0.03%
TARO Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Taro Pharmaceutical Industries Ltd. (TARO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $43.44.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 29.99 and a market capitalization of 1.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.